Patent Assignment
Reel/Frame 067313/0466
Assignment of Assignor's Interest
Recorded: 2024-05-03
Pages: 9
Assignors
BEARD, CLAYTON
Executed: 2023-11-01
CHAPMAN, JULIA NICOLE
Executed: 2023-12-01
MCCOY, DANIEL DAVID
Executed: 2023-11-30
Assignee
BRIDGEBIO GENE THERAPY RESEARCH, INC.
1001 WILLIAM MOORE DRIVE, SUITE 100, RALEIGH, NORTH CAROLINA, 27606
Covered Property
(1)
Gene Therapy for Galactosemia
Application:
18/575,350 →
Publication:
US 2025/0001008
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jun 28, 2024
From: BRIDGEBIO PHARMA, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION
Reel/Frame 067870/0874 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0120 →